These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7865190)

  • 21. [LDL-apheresis for refractory nephrotic syndrome].
    Muso E
    Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K; Tsuji M; Nishimura M; Horimoto M
    J Clin Apher; 2004; 19(1):11-6. PubMed ID: 15095396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure.
    Blazek M; Blaha M; Pecka M; Blaha V; Masin V; Maly J
    Hematology; 2007 Dec; 12(6):571-6. PubMed ID: 17852459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The choice of the optimal regimen for apheresis of the low-density lipoproteins in patients with familial hypercholesterolemia by using mathematical modelling].
    Iarovaia EB; Rostapshova TV; Susekov AV; Kukharchuk VV
    Kardiologiia; 1993; 33(10):50-4, 6. PubMed ID: 8139174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
    Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
    Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
    Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
    Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LDL-apheresis--clinical indication and utility].
    Nakamura T; Ishikawa K
    Nihon Rinsho; 1999 Dec; 57(12):2854-61. PubMed ID: 10638225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
    Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
    Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
    Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992.
    Gordon BR; Saal SD
    Transfus Sci; 1993 Jul; 14(3):261-8. PubMed ID: 10146337
    [No Abstract]   [Full Text] [Related]  

  • 34. LDL-Apheresis removes serum amyloid P and A in hypercholesterolemic patients.
    Palumbo B; Cardinali L; Sinzinger H
    Thromb Res; 2000 Mar; 97(6):491-4. PubMed ID: 10704659
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
    Tojo K; Sakai S; Miyahara T
    Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
    [No Abstract]   [Full Text] [Related]  

  • 37. Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.
    Lepage S; Bonnefont-Rousselot D; Bruckert E; Bourely B; Jaudon MC; Delattre J; Assogba U
    Cardiovasc Drugs Ther; 1996 Nov; 10(5):567-71. PubMed ID: 8950072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
    Nakamura T; Kawagoe Y; Ogawa H; Ueda Y; Hara M; Shimada N; Ebihara I; Koide H
    Am J Kidney Dis; 2005 Jan; 45(1):48-53. PubMed ID: 15696443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
    Solichová D; Bláha M; Aufartová J; Krcmová LK; Plíšek J; Honegrová B; Kasalová E; Lánská M; Urbánek L; Sobotka L
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):105-12. PubMed ID: 26052140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.